Market Entry Analysis for Tuberculosis Diagnostic and Treatment

Client
The Foundation for Innovative New Diagnostics
Faculty
Kathleen Apltauer
Team
Karen Martirosyan, Caroline Nguyen, John Russell, Daniel Silk
The Foundation for Innovative New Diagnostics (FIND) is a Geneva-based nonprofit organization dedicated to accelerating development, evaluation, and use of high-quality, affordable diagnostic tests for poverty-related diseases. FIND is developing a simplified, cost-effective diagnosis and treatment option for the detection of multidrug-resistant tuberculosis (ТВ). To capitalize on this new model, FIND engaged a Capstone team to identify how it can implement the new diagnostic globally. The team researched barriers to market entry, conducted interviews with stakeholders, and identified challenges and opportunities for implementation specific to India, South Africa, and Kyrgyzstan. The team delivered a report to FIND synthesizing the current ТВ landscape for each country and provided recommendations to overcome barriers to entry, integrate new diagnostics tools, and scale up operations.
Capstone Year